Table 1.
Characteristics of 841 HIV+ participants at who initiated combination antiretroviral therapy in the Multicenter AIDS Cohort Study, 1995–2015
| Overall study population (N=841) | Deceased (N=74) | |
|---|---|---|
| Follow-up, years* | 5 (2–12) | 5 (2–8) |
| Age at cART initiation, years | 43 (37–49) | 47 (40–55) |
| Race | ||
| White | 552 (65.6) | 55 (74.3) |
| Black | 184 (21.9) | 15 (20.3) |
| Others | 105 (12.5) | 4 (5.4) |
| cART initiation year | ||
| 1996–2001 | 439 (52.2) | 60 (81.1) |
| 2001–2015 | 402 (47.8) | 14 (18.9) |
| Prior exposure to ART | 409 (48.6) | 56 (75.7) |
| Duration of prior exposure to ART, years | 6 (2–7) | 6 (3–6) |
| Clinically-defined AIDS diagnosis prior to cART initiation | 86 (10.2) | 16 (21.6) |
| Last CD4 cell count within 6 months prior to cART initiation, cells/mm3 | 319 (188–482) | 191 (93–333) |
| First CD4 cell count after cART initiation, cells/mm3 | 417 (260–585) | 292 (122–439) |
| Most recent CD4 cell count, cells/mm3 | 569 (375–761) | 244 (84–424) |
*
Showing median (IQR) for continuous variables or N (%) for categorical variables
Abbreviations: IQR, interquartile range; cART, combination antiretroviral therapy; ART, suboptimal mono- or dual antiretroviral therapy